Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.37 |
| ▸ | CES1 | P23141 | 2/20 | 0.37 |
| ▸ | CES2 | O00748 | 1/20 | 0.36 |
| ▸ | FDPS | P14324 | 6/20 | 0.34 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.32 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10687004 | 0.91 | CES2 (0.41) | CES1CES2ALDH1A1 | |
| SCHEMBL2784167 | 0.84 | CA1 (0.40) | CA1CES1CES2TRPM8 | |
| SCHEMBL11352618 | 0.84 | CA1 (0.48) | CA1ALDH1A1TRPM8 | |
| SCHEMBL11529584 | 0.83 | CES2 (0.39) | CES1CES2FDPSOPRM1ALDH1A1 | |
| SCHEMBL2782959 | 0.81 | CES2 (0.41) | CES1CES2ALDH1A1 | |
| SCHEMBL258041 | 0.81 | FFAR4 (0.44) | CES1CES2FDPSOPRM1SPHK1 | |
| SCHEMBL441191 | 0.81 | CES1 (0.50) | CA1CES1CES2ALDH1A1TP53 | |
| SCHEMBL28179508 | 0.78 | PTPN1 (0.45) | CA1ALDH1A1 | |
| SCHEMBL16594597 | 0.77 | CA1 (0.39) | CA1CES1CES2OPRM1ALDH1A1 | |
| SCHEMBL11568145 | 0.77 | CES1 (0.39) | CA1CES1CES2FDPSALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0361341-A2 | Therapeutics for aids based on inhibitors of HIV protease | MILES INC. (US) | 1990-04-04 | — | — | EP | claimed |
| US-9249257-B2 | Copolymer, organic semiconductor material, organic electrical device, photovoltaic module | MITSUBISHI CHEMICAL CORPORATION (JP) | 2016-02-02 | — | — | US | disclosed |
| US-9212254-B2 | — | — | 2015-12-15 | — | — | US | disclosed |
| EP-2857429-A1 | COPOLYMER, ORGANIC SEMICONDUCTOR MATERIAL, ORGANIC ELECTRICAL DEVICE, AND SOLAR CELL MODULE | Mitsubishi Chemical Corporation (JP) | 2015-04-08 | — | — | EP | disclosed |
| US-20150094436-A1 | COPOLYMER, ORGANIC SEMICONDUCTOR MATERIAL, ORGANIC ELECTRICAL DEVICE, AND PHOTOVOLTAIC MODULE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2015-04-02 | — | — | US | disclosed |
| US-20100143273-A1 | COSMETIC COMPOSITION COMPRISING AT LEAST ONE APROTIC HYDROCARBON-BASED VOLATILE SOLVENT | L'OREAL S.A. (FR) | 2010-06-10 | — | — | US | disclosed |
| EP-2083789-A1 | COSMETIC COMPOSITION COMPRISING AT LEAST ONE APROTIC HYDROCARBON-BASED VOLATILE SOLVENT | L'Oréal (FR) | 2009-08-05 | — | — | EP | disclosed |
| WO-2008061985-A1 | COSMETIC COMPOSITION COMPRISING AT LEAST ONE APROTIC HYDROCARBON-BASED VOLATILE SOLVENT | L'OREAL (FR) | 2008-05-29 | — | — | WO | disclosed |
| EP-0361341-A2 | Therapeutics for aids based on inhibitors of HIV protease | MILES INC. (US) | 1990-04-04 | — | — | EP | disclosed |
| EP-0116227-B1 | TITANIUM TRICHLORIDE CATALYST COMPONENT AND THE PROCESS FOR THE PRODUCTION THEREOF | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1986-04-16 | — | — | EP | disclosed |
| EP-0174162-A2 | Pharmaceutically active dipeptide derivatives | THE WELLCOME FOUNDATION LIMITED (GB) | 1986-03-12 | — | — | EP | disclosed |
| EP-0116227-A1 | Titanium trichloride catalyst component and the process for the production thereof | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1984-08-22 | — | — | EP | disclosed |